Follow us on

Listen To Tulsa's #1 News, Weather, & Traffic Station Online

recent on-air advertisers

Now Playing

News-Talk 740 KRMG
Listen To Tulsa's ...

Posted: 3:00 p.m. Friday, Feb. 22, 2013

FDA approves new breast cancer drug

Kadcyla said to be “one of a kind” medicine

  • comment(1)

(Photo) Cancer drugs
(Photo) Cancer drugs

By Rick Couri

 

 

The new drug is said to be able to find and treat cancer cells while not harming healthy ones. Kadcyla is a combination of Herceptin and a chemo drug as well a chemical binding agent. The chemical allows the drugs to be delivered to the cancer cells, thereby hitting the cancer with a medical double whammy.

The drug was developed by Roche’s Genentech unit.

The drawback at this point is cost, the new drug is said to cost up to $10,000 per month and is only approved for a fifth of patients.

For more information check here.

  • comment(1)

 
 
 

© 2013 Cox Media Group. By using this website, you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad ChoicesAdChoices.